Author(s)

Andrew Kelly¹, Chris T. Derk²

¹Department of Medicine, Pennsylvania Hospital, Philadelphia, PA, USA.
²Division of Rheumatology, University of Pennsylvania, Philadelphia, PA, USA.

Anti-RNA Polymerase III has been recognized as an important autoantibody in Systemic Sclerosis and it is now included in the 2013 ACR/EULAR classification criteria for Systemic Sclerosis. With this manuscript we attempt to review the current data on anti-RNA polymerase II as it relates to Systemic Sclerosis.

Autoantibodies, Systemic Sclerosis, Scleroderma, Anti-RNA Polymerase III, Cancer

Kelly, A. and Derk, C. (2015) Anti-RNA Polymerase III Antibodies in Systemic Sclerosis. Open Journal of Rheumatology and Autoimmune Diseases, 5, 81-86. doi: 10.4236/ojra.2015.53013.